Table 3.
Mean scores across participants on measures relevant to fear avoidance
| Measure | Patients | Mean | |||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | ||
| Visual analogue scale | |||||
| Baseline | 63 | 47 | 37 | 20 | 41.75 |
| Treatment | 69 | 51 | 4 | 3 | 31.75 |
| Follow-up | 31 | 12 | 7 | 15 | 16.25* |
| Tampa scale for kinesiophobia | |||||
| Baseline | 30 | 28 | 37 | 36 | 32.75 |
| Treatment | 34 | 20 | 28 | 18 | 25.00 |
| Follow-up | 31 | 19 | 29 | 17 | 24.00 |
| Pain and impairment relationship scale | |||||
| Baseline | 78 | 48 | 76 | 61 | 65.75 |
| Treatment | 57 | 38 | 45 | 38 | 44.50* |
| Follow-up | 58 | 26 | 51 | 33 | 42.00*** |
| Coping strategies questionnaire–catastrophizing scale | |||||
| Baseline | 3.16 | 1.33 | 3.33 | 1.33 | 2.29 |
| Treatment | 3.66 | 0.67 | 0.67 | 1.17 | 1.54 |
| Follow-up | 2.67 | 0.33 | 0.5 | 0.17 | 0.92** |
| Beck depression inventory | |||||
| Baseline | 14 | 1 | 17 | 5 | 9.25 |
| Treatment | 16 | 1 | 13 | 2 | 8.00 |
| Follow-up | 15 | 0 | 13 | 2 | 7.50 |
| Multidimensional pain inventory–interference scale | |||||
| Baseline | 4.10 | 2.18 | 5.22 | 3.70 | 3.80 |
| Treatment | 4.30 | 1.45 | 3.18 | 2.30 | 2.81 |
| Follow-up | 3.73 | 2.72 | 3.90 | 1.60 | 2.99 |
*p < 0.05; **p < 0.10; ***p = 0.001